Company: ARTL
Filing Date: 2025-07-18
Form Type: 424B5
Source: 0001640334-25-001239
Chunk: 19

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-07-18
Form: 424B5
Chunk 19
---
 share paid by purchasers of shares of common stock in this offering and the net tangible book value per share of common stock immediately after this offering.

On a pro forma basis, after giving effect to our receipt of $6.2 million of estimated net proceeds (after deducting commissions and estimated offering expenses payable by us) from our sale of $6.50 million of common stock in this offering at an assumed offering price of $15.67 per share (the last reported sale price of our common stock on the Nasdaq Capital Market on July 17, 2025), our as adjusted net tangible book value as of March 31, 2025 would have been $4.8 million, or $4.87 per share. This amount would represent an immediate increase in net tangible book value of $7.31 per share of our common stock to existing stockholders and an immediate and substantial dilution in net tangible book value of $10.80 per share of our common stock to new investors purchasing shares of common stock in this offering at the assumed public offering price.

The following table illustrates this hypothetical dilution on a per share basis:

| Public offering price per share                                                              
 Historical net tangible book value per share as of March 31, 2025                            |     |   | 15.67 
 (2.44 | ) |
|:---------------------------------------------------------------------------------------------|:----|:--|------:|:--|
| Increase in net tangible book value per share attributable to new investors in this offering |     | $ |  7.31 |   |
| As adjusted net tangible book value per share after giving effect to this offering           |     | $ |  4.87 |   |
| Dilution per share to new investors participating in this offering                           |     | $ | 10.80 |   |

The information discussed above is illustrative only and will adjust based on the actual public offering price and other terms of this offering determined at pricing and will also be affected by any securities sold by us, if any, pursuant the accompanying base prospectus. An increase of $1.00 per share in the price at which the shares are sold from the assumed offering price of $16.67 per share shown in the table above, assuming all of our common stock in the aggregate amount of $6.50 million is sold at that price, would increase our as adjusted net tangible book value per share after the offering to $5.00 per share and would increase the dilution in net tangible book value per